XBiotech XBIT
NASDAQ XBIT
$2.02 +0.02 (+1.00%)
As of: Oct 20, 2026 · 3:51 PM EDT

XBiotech (XBIT) EBITDA Margin (2020 - 2022)

Updated

XBiotech's EBITDA Margin came in at -794.91% for FY2022, down 672.95 percentage points from -121.96% in FY2021.

Analysis

XBiotech (XBIT) EBITDA Margin (2020 - 2022) Analysis & Trends

  • Per Business Quant, earlier years put EBITDA Margin at -121.96% in FY2021 (-85.51 pp) and -36.45% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,148.30 Bn 1,116.89 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 624.42 Bn 542.95 Bn 17.26 Bn 35.95%
3 AbbVie 509.35 Bn 482.46 Bn 12.70 Bn 49.01%
4 Merck 366.08 Bn 320.46 Bn 12.21 Bn 6.02%
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 33.11%
7 Amgen 236.09 Bn 191.49 Bn 7.24 Bn 46.01%
8 Gilead Sciences 194.04 Bn 168.24 Bn 6.22 Bn -124.26%
9 Pfizer 171.91 Bn 118.56 Bn 10.94 Bn 39.16%
10 XBiotech 61.59 Mn -473.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -336.61%
Jun 30, 2022 -742.94%
Mar 31, 2022 -1,427.00%
Dec 31, 2021 -144.24%
Sep 30, 2021 -67.36%
Jun 30, 2021 -220.27%
Mar 31, 2021 -60.45%
Dec 31, 2020 -82.29%
Sep 30, 2020 -39.07%
Jun 30, 2020 -38.51%
Mar 31, 2020 -12.72%
API Access

XBiotech EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=XBIT&period=max&api_key=YOUR_API_KEY